| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
177,680,000 |
| Market
Cap: |
8.08(B) |
| Last
Volume: |
2,144,916 |
Avg
Vol: |
1,949,015 |
| 52
Week Range: |
$44.82 - $99.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 568 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,762 |
108,398 |
166,494 |
290,334 |
| Total Sell Value |
$463,948 |
$6,570,910 |
$11,277,891 |
$18,676,003 |
| Total People Sold |
8 |
10 |
11 |
11 |
| Total Sell Transactions |
11 |
52 |
61 |
100 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Conroy Kevin T |
President and CEO |
• • – |
2019-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,325 |
920,336 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2019-01-25 |
4 |
AS |
$78.80 |
$24,737,400 |
D/D |
(304,397) |
886,011 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2019-01-24 |
4 |
AS |
$77.79 |
$13,226,226 |
D/D |
(169,109) |
78,963 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2019-01-24 |
4 |
AS |
$77.64 |
$7,172,548 |
D/D |
(90,909) |
33,211 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2019-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
304,397 |
1,190,408 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2019-01-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
169,109 |
248,072 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2019-01-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
90,909 |
124,120 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2019-01-03 |
4 |
AS |
$62.75 |
$99,214 |
D/D |
(1,581) |
78,963 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,687 |
80,544 |
|
- |
|
| Napier Katherine S |
Director |
– • – |
2018-11-12 |
4 |
AS |
$69.00 |
$529,023 |
D/D |
(7,667) |
102,102 |
|
- |
|
| Napier Katherine S |
Director |
– • – |
2018-11-12 |
4 |
OE |
$3.43 |
$26,298 |
D/D |
7,667 |
109,769 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2018-11-12 |
4 |
AS |
$69.00 |
$11,282,466 |
D/D |
(163,514) |
886,011 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2018-11-12 |
4 |
OE |
$0.83 |
$135,717 |
D/D |
163,514 |
1,049,525 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2018-11-07 |
4 |
AS |
$75.01 |
$52,357 |
D/D |
(698) |
28,700 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2018-11-05 |
4 |
AS |
$75.01 |
$2,821,276 |
D/D |
(37,613) |
29,398 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2018-11-01 |
4 |
AS |
$69.62 |
$4,045,342 |
D/D |
(57,517) |
67,011 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2018-10-31 |
4 |
A |
$13.26 |
$10,011 |
D/D |
755 |
33,211 |
|
- |
|
| Napier Katherine S |
Director |
– • – |
2018-10-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,095 |
102,102 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2018-10-31 |
4 |
AS |
$75.35 |
$1,669,499 |
D/D |
(22,156) |
124,528 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2018-10-08 |
4 |
AS |
$68.20 |
$4,022,933 |
D/D |
(58,000) |
146,684 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2018-10-01 |
4 |
AS |
$79.51 |
$174,118 |
D/D |
(2,190) |
75,857 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2018-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,688 |
78,047 |
|
- |
|
| Wyzga Michael S |
Director |
– • – |
2018-08-28 |
4 |
AS |
$74.85 |
$184,730 |
D/D |
(2,468) |
9,112 |
|
- |
|
| Fallon John A. |
Director |
– • – |
2018-07-30 |
4 |
AS |
$58.86 |
$139,675 |
D/D |
(2,373) |
33,767 |
|
- |
|
| Carey Thomas D. |
Director |
– • – |
2018-07-30 |
4 |
AS |
$58.86 |
$201,713 |
D/D |
(3,427) |
48,983 |
|
- |
|
957 Records found
|
|
Page 20 of 39 |
|
|
0.20 (0.44%) 
